Cargando…
Thromboembolic Disease in COVID-19
Coronavirus disease 2019 (COVID-19) was initially recognized in late December 2019 and has quickly spread globally with over 114 million reported cases worldwide at the time of this publication. For the majority of patients infected with COVID-19, the clinical manifestations are absent or mild. In m...
Autores principales: | Tarmey, Tara, Cullen, Grace, Patel, Tanay Y., Tandon, Yasmeen Kour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific Scholar
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053433/ https://www.ncbi.nlm.nih.gov/pubmed/33880241 http://dx.doi.org/10.25259/JCIS_108_2020 |
Ejemplares similares
-
Anticoagulation failure in pulmonary thromboembolism in COVID-19 pneumonia despite prolonged anticoagulation: A case series
por: Sapkota, Prakash, et al.
Publicado: (2022) -
Chronic thromboembolic pulmonary hypertension
por: Kim, Nick H., et al.
Publicado: (2019) -
Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia
por: Issa, Hussain, et al.
Publicado: (2011) -
Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency
por: James, Andra H, et al.
Publicado: (2013) -
COVID-19 Related Cerebrovascular Thromboembolic Complications in Three Young Patients
por: Haroon, Khawaja Hassan, et al.
Publicado: (2020)